Phibro Animal Health Co. to Post FY2024 Earnings of $1.12 Per Share, Zacks Research Forecasts (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) – Investment analysts at Zacks Research dropped their FY2024 earnings per share estimates for shares of Phibro Animal Health in a report issued on Tuesday, July 23rd. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.12 for the year, down from their previous estimate of $1.13. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.13 per share.

Other analysts have also recently issued research reports about the company. StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Tuesday, April 9th. Barclays raised their price objective on Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research report on Friday, May 10th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $14.75.

Phibro Animal Health Stock Up 0.2 %

Shares of NASDAQ PAHC opened at $18.83 on Friday. The company has a current ratio of 3.16, a quick ratio of 1.67 and a debt-to-equity ratio of 1.69. The stock has a market capitalization of $762.62 million, a PE ratio of 58.85, a price-to-earnings-growth ratio of 4.90 and a beta of 0.57. The stock’s fifty day simple moving average is $17.74 and its two-hundred day simple moving average is $14.65. Phibro Animal Health has a 12-month low of $9.40 and a 12-month high of $19.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, May 8th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. The business had revenue of $263.20 million for the quarter, compared to analysts’ expectations of $251.82 million. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 26th. Investors of record on Wednesday, June 5th were paid a $0.12 dividend. The ex-dividend date was Wednesday, June 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.55%. Phibro Animal Health’s dividend payout ratio (DPR) is 150.00%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund raised its stake in Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after acquiring an additional 765 shares during the last quarter. Acadian Asset Management LLC raised its stake in Phibro Animal Health by 32.8% in the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company’s stock worth $8,726,000 after acquiring an additional 166,776 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Phibro Animal Health by 290.2% in the 4th quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock worth $849,000 after acquiring an additional 54,506 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its stake in Phibro Animal Health by 358.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock worth $27,000 after acquiring an additional 1,843 shares during the last quarter. Finally, Wellington Management Group LLP raised its stake in Phibro Animal Health by 165.9% in the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock worth $1,908,000 after acquiring an additional 102,793 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.